Neuromodulation Techniques After SCI
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Richmond, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 4 people enrolled
- Started
- 1 Jun 2020
- Ended
- 31 Dec 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- EAW+SCES (exoskelton and spinal cord epidural stimulation)
- EAW+TS (exoskelton and transspinal stimulation)
- Record updated
- 28 April 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- All participants will be between 18-70 years old, male, with traumatic motor complete SCI and level of injury of T10 and above, as determined by EMG testing and International Standards for Neurological Classification of SCI (ISNCSCI) exam
- All participants will undergo ISNCSCI examination for neurological level and function and only those with American Spinal Injury Classification (AIS A and B; i.e. motor deficit below the level of injury) will be included
Who cannot take part
- Functional upper and lower extremity ROM, strength, spasticity and skin integrity will also have assessed prior to enrollment in the program; The Modified Ashworth Scale will be used to ensure safety of the participants prior to engagement in the rehabilitation program; Participants with severe spasticity or limited ROM will be excluded from the trial; This is based on the Ekso manufacturer's recommendations
- Participants with any of the following pre-existing medical conditions will be excluded from the current trial:
- Untreated or uncontrolled hypertension defined as high resting blood pressure greater than 140/90 mmHg and severe orthostatic hypotension (drop greater than 20 mmHg compared to resting supine blood pressure) or incapable to maintain a sitting or EAW standing posture
- Other medical conditions including cardiovascular disease, uncontrolled type II DM, uncontrolled hypertension, and those on insulin, pressures sores stage 3 or greater, or symptomatic urinary tract infection
- Pressure ulcer of the trunk, pelvic area, or lower extremities of grade 3 or more
- Any condition that, in the judgment of the principal investigator or medical provider, precludes safe participation in the study and/or increases the risk of infection
- Taking anti-coagulants or anti-platelet agents, including aspirin if unable to be off this medication for medical reasons
- Diagnosis of neurological injury other than SCI, including cauda equina or distal conus injuries resulting in limb or sacral areflexia
- Unhealed fracture in either lower or upper extremities
- Severe scoliosis, hip knee range of motion (ROM) or flexion knee contractures preventing positioning in an exoskeleton or plantarflexion contracture greater than 20 degrees
- Unable to fit in the device for any reason
- Implanted pacemakers and/or implanted defibrillator devices
- DXA T-Score less than -2.5. Scans done will include total body, dual hips and knees. Total hip BMD T-scores < -3.5 and knee BMD scores of less than 0.6 g/cm2
- Untreatable severe spasticity judged to be contraindicated by the site Physician
- Psychopathology documentation in the medical record or history that may conflict with study objectives
Where in United States
- Hunter Holmes McGuire VA Medical Center, Richmond, VARichmond, United States
About the trial
What the trial wants to find out
Spinal cord injury (SCI) leads to several health-related consequences often linked to reduced levels of physical activity. Direct stimulation of the spinal cord, either through implanted devices or surface stimulation, has been combined with intense physical therapy assisted treadmill walking to facilitate independent standing and stepping. These current methods require 3-4 highly skilled therapists and may not be feasible in all rehabilitation settings, especially when considering the growing number of SCI patients each year. Therefore, the use of robotic exoskeleton suits combined with direct stimulation of the spinal cord (requiring 1-2 therapists) may offer an alternative rehabilitation approach to overcome their limited abilities to stand and walk. Such improvements may also help to reverse or eliminate other health-related consequences associated with SCI. The pilot work will provide the preliminary evidence required to design future clinical trials for Veterans and civilians with SCI to restore overground mobility.
The 2 groups in the trial
- EAW+SCESTreatment being tested
Three months of exoskeleton training followed by 6 months of epidural stimulation.
Treatment: EAW+SCES (exoskelton and spinal cord epidural stimulation)
- EAW+TSTreatment being tested
Three months of exoskeleton training followed by 6 months of transspinal stimulation.
Treatment: EAW+TS (exoskelton and transspinal stimulation)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Transspinal Versus Epidural Stimulation for Exoskeletal Assisted Walking After Spinal Cord Injury
- Record updated
- 28 April 2026